Therapeutic Efficacy of Antioxidants in Ameliorating Obesity Phenotype and Associated Comorbidities
Obesity has been a worldwide epidemic for decades. Despite the abundant increase in knowledge regarding the etiology and pathogenesis of obesity, the prevalence continues to rise with estimates predicting considerably higher numbers by the year 2030. Obesity is characterized by an abnormal lipid acc...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-08-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2020.01234/full |
id |
doaj-186f95cae2814caf9136d94cf8e476f6 |
---|---|
record_format |
Article |
spelling |
doaj-186f95cae2814caf9136d94cf8e476f62020-11-25T03:52:34ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122020-08-011110.3389/fphar.2020.01234581131Therapeutic Efficacy of Antioxidants in Ameliorating Obesity Phenotype and Associated ComorbiditiesSteven TunCaleb James SpainhowerCameron Lee CottrillHari Vishal LakhaniSneha S. PillaiAnum DilipHibba ChaudhryJoseph I. ShapiroKomal SodhiObesity has been a worldwide epidemic for decades. Despite the abundant increase in knowledge regarding the etiology and pathogenesis of obesity, the prevalence continues to rise with estimates predicting considerably higher numbers by the year 2030. Obesity is characterized by an abnormal lipid accumulation, however, the physiological consequences of obesity are far more concerning. The development of the obesity phenotype constitutes dramatic alterations in adipocytes, along with several other cellular mechanisms which causes substantial increase in systemic oxidative stress mediated by reactive oxygen species (ROS). These alterations promote a chronic state of inflammation in the body caused by the redox imbalance. Together, the systemic oxidative stress and chronic inflammation plays a vital role in maintaining the obese state and exacerbating onset of cardiovascular complications, Type II diabetes mellitus, dyslipidemia, non-alcoholic steatohepatitis, and other conditions where obesity has been linked as a significant risk factor. Because of the apparent role of oxidative stress in the pathogenesis of obesity, there has been a growing interest in attenuating the pro-oxidant state in obesity. Hence, this review aims to highlight the therapeutic role of antioxidants, agents that negate pro-oxidant state of cells, in ameliorating obesity and associated comorbidities. More specifically, this review will explore how various antioxidants target unique and diverse pathways to exhibit an antioxidant defense mechanism.https://www.frontiersin.org/article/10.3389/fphar.2020.01234/fullobesityoxidative stressantioxidantsadipocytescardiovascular diseasediabetes |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Steven Tun Caleb James Spainhower Cameron Lee Cottrill Hari Vishal Lakhani Sneha S. Pillai Anum Dilip Hibba Chaudhry Joseph I. Shapiro Komal Sodhi |
spellingShingle |
Steven Tun Caleb James Spainhower Cameron Lee Cottrill Hari Vishal Lakhani Sneha S. Pillai Anum Dilip Hibba Chaudhry Joseph I. Shapiro Komal Sodhi Therapeutic Efficacy of Antioxidants in Ameliorating Obesity Phenotype and Associated Comorbidities Frontiers in Pharmacology obesity oxidative stress antioxidants adipocytes cardiovascular disease diabetes |
author_facet |
Steven Tun Caleb James Spainhower Cameron Lee Cottrill Hari Vishal Lakhani Sneha S. Pillai Anum Dilip Hibba Chaudhry Joseph I. Shapiro Komal Sodhi |
author_sort |
Steven Tun |
title |
Therapeutic Efficacy of Antioxidants in Ameliorating Obesity Phenotype and Associated Comorbidities |
title_short |
Therapeutic Efficacy of Antioxidants in Ameliorating Obesity Phenotype and Associated Comorbidities |
title_full |
Therapeutic Efficacy of Antioxidants in Ameliorating Obesity Phenotype and Associated Comorbidities |
title_fullStr |
Therapeutic Efficacy of Antioxidants in Ameliorating Obesity Phenotype and Associated Comorbidities |
title_full_unstemmed |
Therapeutic Efficacy of Antioxidants in Ameliorating Obesity Phenotype and Associated Comorbidities |
title_sort |
therapeutic efficacy of antioxidants in ameliorating obesity phenotype and associated comorbidities |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Pharmacology |
issn |
1663-9812 |
publishDate |
2020-08-01 |
description |
Obesity has been a worldwide epidemic for decades. Despite the abundant increase in knowledge regarding the etiology and pathogenesis of obesity, the prevalence continues to rise with estimates predicting considerably higher numbers by the year 2030. Obesity is characterized by an abnormal lipid accumulation, however, the physiological consequences of obesity are far more concerning. The development of the obesity phenotype constitutes dramatic alterations in adipocytes, along with several other cellular mechanisms which causes substantial increase in systemic oxidative stress mediated by reactive oxygen species (ROS). These alterations promote a chronic state of inflammation in the body caused by the redox imbalance. Together, the systemic oxidative stress and chronic inflammation plays a vital role in maintaining the obese state and exacerbating onset of cardiovascular complications, Type II diabetes mellitus, dyslipidemia, non-alcoholic steatohepatitis, and other conditions where obesity has been linked as a significant risk factor. Because of the apparent role of oxidative stress in the pathogenesis of obesity, there has been a growing interest in attenuating the pro-oxidant state in obesity. Hence, this review aims to highlight the therapeutic role of antioxidants, agents that negate pro-oxidant state of cells, in ameliorating obesity and associated comorbidities. More specifically, this review will explore how various antioxidants target unique and diverse pathways to exhibit an antioxidant defense mechanism. |
topic |
obesity oxidative stress antioxidants adipocytes cardiovascular disease diabetes |
url |
https://www.frontiersin.org/article/10.3389/fphar.2020.01234/full |
work_keys_str_mv |
AT steventun therapeuticefficacyofantioxidantsinamelioratingobesityphenotypeandassociatedcomorbidities AT calebjamesspainhower therapeuticefficacyofantioxidantsinamelioratingobesityphenotypeandassociatedcomorbidities AT cameronleecottrill therapeuticefficacyofantioxidantsinamelioratingobesityphenotypeandassociatedcomorbidities AT harivishallakhani therapeuticefficacyofantioxidantsinamelioratingobesityphenotypeandassociatedcomorbidities AT snehaspillai therapeuticefficacyofantioxidantsinamelioratingobesityphenotypeandassociatedcomorbidities AT anumdilip therapeuticefficacyofantioxidantsinamelioratingobesityphenotypeandassociatedcomorbidities AT hibbachaudhry therapeuticefficacyofantioxidantsinamelioratingobesityphenotypeandassociatedcomorbidities AT josephishapiro therapeuticefficacyofantioxidantsinamelioratingobesityphenotypeandassociatedcomorbidities AT komalsodhi therapeuticefficacyofantioxidantsinamelioratingobesityphenotypeandassociatedcomorbidities |
_version_ |
1724482102981820416 |